Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Genes and microbes converge in colitis: Both host genetics and intestinal microbes probably contribute to a person's overall susceptibility to inflammatory bowel disease (IBD). The human gut microbe Bacteroides fragilis produces immunomodulatory molecules that it releases via outer membrane vesicles (OMVs). These molecules can protect mice from experimentally induced colitis. Chu et al. now find that OMV-mediated protection from colitis requires Atg16l1 and Nod2 genes whose human orthologs are associated with an increased risk for developing IBD. OMVs trigger an ATG16L1 and NOD2–dependent noncanonical autophagy pathway in dendritic cells (DCs). OMV-primed DCs, in turn, induce regulatory T cells in the intestine that protect against colitis. Science , this issue p. 1116
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“commensal Bacteroides fragilis‐induced activation of LAP drives a transcriptionally tolerogenic program of differentiation in antigen‐presenting cells, which is required to generate immunosuppressive TREG cells in the context of colitis (Chu et al, 2016).”
From Autophagy in major human diseases (2021) · cites this paper as Chu et al, 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Martinez, J., Malireddi, R. K. S., Lu, Q., Cunha, L. D., Pelletier, S., Gingras, S., Orchard, R., Guan, J.-L., Tan, H., Peng, J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3192 · Cited by 758 · cited 12×
“Data are representative of at least three independent experiments, with three to nine mice per group. a known product of LAP activation (36), but at significantly reduced levels in Nod2−/− or Tlr2−/− DCs (fig.”
BackgroundInfluentialSelf-citationRetractedGenome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385 · cited 2×
“Intestinal microbiota modulate development and function of the immune system, and play a critical role in inflammatory bowel disease (IBD), a family of idiopathic intestinal disorders including Crohn’s disease (CD) and ulcerative colitis (UC) (1-6).”
BackgroundA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722 · cited 2×
“published online EpubJan (S0016-5085(11)01378-3 [pii]10.”
Self-citationInteractions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 2×
“Intestinal microbiota modulate development and function of the immune system, and play a critical role in inflammatory bowel disease (IBD), a family of idiopathic intestinal disorders including Crohn’s disease (CD) and ulcerative colitis (UC) (1-6).”
BackgroundAntimicrobial Autophagy: A Conserved Innate Immune Response in Drosophila
Moy, R. H., & Cherry, S. (2013) · Journal of Innate Immunity · doi:10.1159/000350326 · Cited by 3,539
A microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340 · cited 1×
“fragilis capsular Polysaccharide A (PSA) is packaged in outer membrane vesicles (OMVs) and delivered to intestinal dendritic cells to induce interleukin-10 (IL-10) production from CD4+Foxp3+ regulatory T cells (Tregs), which protect from experimental colitis (30-32).”
BackgroundSelf-citation
Cited by
Items 401–500 of 645
Microcapsules based on biological macromolecules for intestinal health: A review
Xu, M., Feng, G., & Fang, J. Q. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133956 · Cited by 16
Zhu, J., Liu, Y. L., Chen, T., Feng, F., Fang, T., Zhang, W., Li, Y., Ju, Y., Xu, L., Zhuge, X., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202500754 · Cited by 15
Human intestinal epithelial cells can internalize luminal fungi via LC3-associated phagocytosis
Cohen‐Kedar, S., Barda, E. S., Rabinowitz, K. M., Keizer, D., Abu-Taha, H., Schwartz, S., Kaboub, K., Baram, L., Sadot, E., White, I. D., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1142492 · Cited by 12
“Using patient derived organoids (73), our findings may allow the assessment of epithelial phagocytic capabilities under defined genetic (e.g. ATG16L1 variants) and experimental inflammatory conditions and evaluate their contribution to homeostasis or if perturbed, to the pathogenesis of IBD.”
Yin, L., Jiang, X., Wang, M., Yang, Y., He, Z., Sun, J., Gao, H., & Sun, M. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.110224 · Cited by 17
Padilha, M. D. M., Melo, F. T. D. V., Laurentino, R. V., da Silva, A. N. M. R., & Feitosa, R. N. M. (2024) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2024.104468 · Cited by 15
“17 Alteration in gut homeostasis alters the microbiome contributing to the pathogenesis of many disorders, including liver disease.”
Huang, Z., Peng, H.-L., Sun, Y., Zhu, X.-M., Zhang, H., Jiang, L., Zhao, Q., & Xiong, H. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103560 · Cited by 11
Gao, H., & Liu, Z. (2023) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbad017 · Cited by 13
Bai, W., Bai, J., Li, Y., Tian, D., & Shi, R. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.02.034 · Cited by 12
Wu, J., An, M., Zhu, J., Tan, Z., Chen, G., Stidham, R. W., & Lubman, D. M. (2019) · Journal of Proteomics & Bioinformatics · doi:10.4172/0974-276x.1000494 · Cited by 12
Sorrentino, D. R., Nguyen, V. Q. C., & Chitnavis, M. V. (2019) · Cells · doi:10.3390/cells8060548 · Cited by 13
“inflammation in response to Bacteroides protein secretions [98].”
BackgroundPathogenesis Mediated by Bacterial Membrane Vesicles
Gilmore, W. J., Bitto, N. J., & Kaparakis‐Liaskos, M. (2021) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-67171-6_6 · Cited by 14
Olbjørn, C., Småstuen, M. C., & Moen, A. E. F. (2022) · Microorganisms · doi:10.3390/microorganisms10071273 · Cited by 13
“Disturbances in the gut microbiota are thought to be important in the development of IBD [1], and a leading hypothesis is that the intestinal inflammation is caused by an inappropriate immune response to commensal bacteria in genetically susceptible individuals [2].”
BackgroundThe Role of the Microbiome in the Etiology of Inflammatory Bowel Diseases
Halper-Stromberg, A., & Dalal, S. R. (2023) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0042-1760680 · Cited by 15
Emerging role of Jumonji domain-containing protein D3 in inflammatory diseases
Li, X., Chen, R.-Y., Shi, J., Li, C., Liu, Y.-J., Gao, C., Gao, M.-R., Zhang, S., Lu, J., Cao, J.-F., et al. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.100978 · Cited by 12
“Thus, JMJD3 may be involved in modulating in fl ammatory responses during intestinal in fl ammation [149].”
BackgroundYOD1 sustains NOD2-mediated protective signaling in colitis by stabilizing RIPK2
Shen, J., Lou, L., Du, X., Zhou, B., Xu, Y., Mei, F., Wu, L., Li, J., Waisman, A., Ruan, J., et al. (2024) · EMBO Reports · doi:10.1038/s44319-024-00276-6 · Cited by 11
Wu, J., Ye, W., Yu, J., Zhou, T., Zhou, N., Ng, D. K. P., & Li, Z. (2025) · Essays in Biochemistry · doi:10.1042/ebc20253003 · Cited by 15
Rahaman, M. M., Wangchuk, P., & Sarker, S. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107608 · Cited by 15
San-Martín, M. I., Chamizo‐Ampudia, A., Sanchiz, Á., Ferrero, M. Á. M., Martínez-Blanco, H., Rodríguez-Aparicio, L. B., & Navasa, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104818 · Cited by 16
“Elevated levels of pathogenic bacteria, including Escherichia coli [10,11] and Klebsiella [12,13], alongside reduced levels of beneficial microbes such as Clostridium species [14,15] and Bacteroides fragilis [16,17] have been reported.”
Exosome-based mucosal therapeutic and diagnostic system: towards clinical translation
Liu, X., Teng, X., Wang, J., Zhang, G., Guo, W. F., Zhang, W., Zhao, Q., Hu, C. H., Sun, L., & Mao, Y. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113966 · Cited by 18
Gautier, T., Oliviero, N., Ferron, S., Pogam, P. L., Gall‐David, S. L., Sauvager, A., Leroyer, P., Cannie, I., Dion, S., Sweidan, A., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1023315 · Cited by 12
“fragilis, regularly maintain intestinal homeostasis, they are also known to have altered functions during infection and diseases to ensure host survival (Chu et al., 2016; Durant et al., 2020; Engevik et al., 2021; Gul et al., 2022).”
BackgroundXia, P., Hou, T., Jin, H., Meng, Y., Li, J., Zhan, F., Geng, F., & Li, B. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2204147 · Cited by 11
“Additionally, PSA stimulated CD4 + T to secrete IL-10 or was delivered to dendritic cells (DCs) to induce CD4 + Foxp3 + regulatory T cells (Tregs) to produce IL-10 to prevent inflammatory diseases (Chu et al. 2016; Mazmanian, Round, and Kasper 2008).”
Calva-Cruz, O. D. J., Ovando‐Vázquez, C., León‐Rodríguez, A. D., Veana, F., Rangel, E. E., Treviño, S., & de la Rosa, A. P. B. (2023) · Foods · doi:10.3390/foods12142760 · Cited by 15
“response and suppressing intestinal inflammation [65]; thus, a deep characterization should be carried out to identify the B.”
BackgroundSystems biology in inflammatory bowel diseases: on the way to precision medicine
Dovrolis, N., Filidou, E., & Kolios, G. (2019) · Annals of Gastroenterology · doi:10.20524/aog.2019.0373 · Cited by 16
“Chu et al [181] described how outer membrane vesicles secreted by Bacteroides fragilis play a role in the immunomodulation of IBD in partnership with the NOD2 and ATG16L1 genes.”
BackgroundZhu, J., Wang, Z., Chen, F., & Liu, C. (2019) · PeerJ · doi:10.7717/peerj.8061 · Cited by 11
Gan, R., Ni, E., Li, G., & Chen, W. (2025) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.70022 · Cited by 16
Effect of Probiotics on Improving Intestinal Mucosal Permeability and Inflammation after Surgery
Kim, M., Lee, Y. J., Hussain, Z., & Park, H. (2024) · Gut and Liver · doi:10.5009/gnl240170 · Cited by 13
Salivary exosomes exacerbate colitis by bridging the oral cavity and intestine
Yang, C., Chen, J., Zhao, Y., Wu, J., Xu, Y., Xu, J. L., Chen, F., Chen, Y., & Chen, N. (2024) · iScience · doi:10.1016/j.isci.2024.111061 · Cited by 13
“23 Hence, an in-depth investigation into the pathogenesis of this condition holds particular significance, particularly in elucidating the mechanisms underlying recurrent intestinal inflam-mation in IBD.”
The metabolic and immunomodulatory functions of Bacteroides fragilis; a next-generation probiotic?
Roustapoor, R., Abdi, E., Khabbaz, A., & Abdi, A. (2025) · Medicine in Microecology · doi:10.1016/j.medmic.2025.100137 · Cited by 12
Autophagy and Apoptosis in Inflammatory Bowel Disease
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2023) · Gastroenterology Insights · doi:10.3390/gastroent14040042 · Cited by 11
Laing, B. B., Barnett, M. P. G., Marlow, G., Nasef, N. A., & Ferguson, L. R. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1505497 · Cited by 12
“fragilis delivers immunomodulatory molecules to immune cells via secretion of outer membrane vesicles (OMVs) [60].”
Guo, W., Wang, X., Liu, F., Chen, S., Wang, S., Zhang, Q., Yuan, L., & Du, S. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12877 · Cited by 10
A broken network of susceptibility genes in the monocytes of Crohn’s disease patients
Liu, H., Guan, L., Su, X., Zhao, L., Shu, Q., & Zhang, J. (2024) · Life Science Alliance · doi:10.26508/lsa.202302394 · Cited by 9
“Chu et al described that ATG16L1/NOD2 and microbiome cooperate to promote bene fi cial immune responses (41).”
BackgroundJiang, L., Ma, X., Qi, Y., Pu, D., Xu, F., & Zhang, D. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125155 · Cited by 10
Pu, Y., Huang, S., Gao, S., Duan, Y., Li, W., Li, Q., Lin, H., Zhang, K., Zhou, M., & Wu, W. Z. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.06.022 · Cited by 9
“Although the pathogenesis of IBD remains unclear, accumulating evidence suggests that it may be attributed to chronic relapsing inflammation of the gastrointestinal tract and gut microbiota dysregulation 5-7 .”
Self-citationDan, W., Xiong, C., Zhou, G., Chen, J., & Pan, F. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189381 · Cited by 11
Microbiome engineering: unlocking therapeutic potential in inflammatory bowel disease
Chen, K., Huang, L.-B., Yang, M., Yue, N.-N., Luo, D., Zhang, Y., Tian, C., Song, Y., Wei, D., Shi, R., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1610029 · Cited by 17
“…Gram-negative and Gram-positive bacteria, mediate important interactions within the intestinal microenvironment through intercellular and cross-species communication, thereby maintaining intestinal homeostasis (Toyofuku et al., 2019; Pegtel and Gould, 2019; Jiang et al., 2016; Chu et al., 2016).”
Zhao, S., Zhu, L., Feng, W., Zhang, L., Chen, D., Hu, Y.-C., & Shen, H. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10808 · Cited by 10
Bu, Y., Shih, K. C., Wong, H. L., Kwok, S. S., Lo, A., Chan, J. Y.-K., Ng, A. L. K., Chan, T. C. Y., Jhanji, V., & Tong, L. H. T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1063069 · Cited by 10
“From new evidence gathered, the composition of our gut microbiome plays an important role in the development of autoimmune diseases, including demyelinating disease, inflammatory bowel disease (IBD), and autoimmune uveitis (8).”
BackgroundGut Microbiome: An Intersection between Human Genome, Diet, and Epigenetics
Muhammad, A. Y., Amonov, M., Baig, A. A., & Alvi, F. J. (2024) · Advanced Gut & Microbiome Research · doi:10.1155/2024/6707728 · Cited by 15
Bianchi, M. G., Chiu, M., Taurino, G., Ruotolo, R., Marmiroli, N., Bergamaschi, E., Cubadda, F., & Bussolati, O. (2020) · Nanomaterials · doi:10.3390/nano10071395 · Cited by 10
“In particular, autophagy is required to avoid excessive inflammation on the basis of signals derived from gut microbiota [47].”
BackgroundCurrent Paradigms to Explore the Gut Microbiota Linkage to Neurological Disorders
Sharma, V., Sankhyan, A., Varshney, A., Choudhary, R., & Sharma, A. K. (2020) · EMJ Neurology · doi:10.33590/emjneurol/20-00068 · Cited by 10
Tang, C., Wu, Y., Tao, Q., Zeng, C., & Chen, Y. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101121 · Cited by 8
Hu, X., Wu, Q., Huang, L., Xu, J., He, X., & Wu, L. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1465499 · Cited by 9
Advanced biomaterials and delivery modalities to alleviate cancer therapy-induced inflammation
Huang, H., Ke, Q., Li, T., Yang, Z., Shen, J., Li, Z., Zeng, Q., Wei, X., Yang, H., Wang, D., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123419 · Cited by 9
Autophagy in inflammatory bowel disease: immunization, etiology, and therapeutic potential
Miao, Z.-X., Meng, H., Wang, J., Hou, X.-T., Cheng, W., Liu, B., Zhang, Q., & Yuan, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1543040 · Cited by 13
Mechanistic and therapeutic advances in immune-mediated gastrointestinal disorders
Garabatos, N., Angelats, E., & Santamaría, P. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.07.024 · Cited by 8
Liu, H., Hu, Q., Yan, Q., Hao, Z., & Liang, C. Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1266446 · Cited by 8
Current and future microbiome-based therapies in inflammatory bowel disease
Montrose, J. A., Kurada, S. V., & Fischer, M. (2024) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001027 · Cited by 9
Matsumoto, H., Sasahira, M., Go, T. T., Yo, S., Ninomiya, T., Osawa, M., Handa, O., Umegami, E., Inoüe, R., & Shiotani, A. (2024) · Biomedicines · doi:10.3390/biomedicines12092125 · Cited by 12
“However, the mechanism of UC remains unclear [2–4].”
BackgroundGut commensal bacteria, Paneth cells and their relations to radiation enteropathy
Gao, Y.-L., Shao, L., Dong, L., & Chang, P. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i3.188 · Cited by 8
Sun, D., Wang, C., Sun, L., Hu, L., Fang, Z., Deng, Q., Zhao, J. J., & Gooneratne, R. (2022) · Nutrients · doi:10.3390/nu14040776 · Cited by 8
“Phascolarctobacterium, Akkermansia, Megasomonas and Lactobacillus have all been reported to reduce inflammation and play a beneficial role in the control of inflammation [33].”
BackgroundIntestinal microbiota-derived membrane vesicles and their role in chronic kidney disease
Wu, Q. Y., Liu, B. C., Ruan, X. Z., & Ma, K. L. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166478 · Cited by 7
Loganes, C., Pin, A., Naviglio, S., Girardelli, M., Bianco, A. M., Martelossi, S., Tommasini, A., & Piscianz, E. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i41.9117 · Cited by 8
Ménage à trois: regulation of host immunity by enteric neuro-immune-microbiota cross talks
Yissachar, N. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.10.006 · Cited by 9
Zhang, P., Minardi, L. M., Kuenstner, J. T., Zekan, S. M., Zhu, F., Hu, Y., & Kruzelock, R. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/116574 · Cited by 9
Richie, T. G., Heeren, L., Kamke, A., Pogranichniy, S., Monk, K., Summers, T., Wiechman, H., Ran, Q., Sarkar, S., Plattner, B. L., et al. (2023) · mSystems · doi:10.1128/msystems.00703-23 · Cited by 8
Commensal microbiome dysbiosis elicits interleukin-8 signaling to drive fibrotic skin disease
Zhang, W., Peng, Q., Huang, X., Huang, Q., Zhang, Z., Li, F., Zheng, N., Shi, B., Fan, Z., Maj, T., et al. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae273 · Cited by 9
“For example, intestinal microbiota is a key driver of inflammatory bowel disease, which develops further to intestinal fibrosis (12 ).”
BackgroundBajaj, A., Markandey, M., Samal, A., Goswami, S., Vuyyuru, S. K., Mohta, S., Kante, B., Kumar, P., Makharia, G., Kedia, S., et al. (2024) · Gut Pathogens · doi:10.1186/s13099-024-00654-4 · Cited by 9
“Previous studies have indicated the loss of stability of the microbiome in IBD, with multiple studies including the current one, reporting the loss of diversity and diminishment of certain microbial taxa in gut inflammatory disorders [48–51].”
BackgroundTherapeutic Effect of Membrane Vesicle Drug Delivery Systems in Inflammatory Bowel Disease
Zhao, Z., Li, Z., Gu, Y.-H., & Gu, R. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091127 · Cited by 7
“Notably, in genetically susceptible individuals, such as those with an ATG16L1 deficiency, this OMV-mediated immune remodeling offers a promising strategy for correcting Treg dysfunction [78].”
Comstock, L. E. (2025) · Journal of Bacteriology · doi:10.1128/jb.00346-25 · Cited by 10
Zhang, F., Wang, H., Kamila, B., Xiong, J., Li, P., Sun, X., Huang, J., Xu, B., Wang, X., & Lü, X. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.124750 · Cited by 9
The Conjunctival Microbiome and Dry Eye: What We Know and Controversies
Shih, K. C., & Tong, L. H. T. (2024) · Eye & Contact Lens Science & Clinical Practice · doi:10.1097/icl.0000000000001077 · Cited by 7
“19 From new evidence gathered, the composition of our gut microbiome plays an important role in the development of autoimmune diseases, including demyelinating disease, in fl ammatory bowel disease, 20 and autoimmune uveitis.”
BackgroundNeutrophil Engulfment in Cancer: Friend or Foe?
Lu, T., & Li, W. (2025) · Cancers · doi:10.3390/cancers17030384 · Cited by 9
“…For example, dendritic cells with impaired LAP function exhibit reduced ability to induce T-regs, which are important for suppressing inflammation [130]. example, dendritic cells with impaired LAP function exhibit reduced ability to induce T-regs, which are important for suppressing in fl ammation…”
Varma, M., Kadoki, M., Lefkovith, A. J., Conway, K. L., Gao, K. M., Mohanan, V., Tusi, B. K., Graham, D. B., Latorre, I. J., Tolonen, A. C., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900750 · Cited by 9
“Moreover, autophagy controls T cell homeostasis and attrition (27–29), and Atg16L1 is specifically required for Treg maintenance of peripheral tolerance (30, 31).”
BackgroundSelf-citationWang, H., Teng, J., Wang, M., Zhang, Y., Liu, X., & Liu, Z. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.814 · Cited by 7
“Despite extensive research, the etiology and pathogenesis of UC remain unclear.(2,3) Some scholars suggest that UC is caused by immune dysfunction and environmental factors affecting the genetically susceptible populations, while others believe that it is caused by nitrification stress.”
BackgroundRetractedJohnson, L. A., Rodansky, E. S., Moons, D. S., Larsen, S. D., Neubig, R. R., & Higgins, P. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw210 · Cited by 12
Impact of environmental factors on alloimmunity and transplant fate
Riella, L. V., Bagley, J., Iacomini, J., & Alegre, M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90596 · Cited by 7
Xu, D., Guo, T., He, Y., Gao, S., Su, J., Pan, H., & Li, A. (2025) · Animals · doi:10.3390/ani15091231 · Cited by 6
“Under intestinal microbiota disorder, IBD susceptibility genes are overexpressed, exacerbating the inflammatory response [3].”
Yang, J. C., Zhao, M. Y., Chernikova, D. A., Arias-Jayo, N., Zhou, Y. K., Situ, J., Gutta, A., Chang, C., Liang, F., Lagishetty, V., et al. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08647-8 · Cited by 6
“Therefore, interrogating whether CD risk variants can be disease-driving “microbiome quantitative trait loci” (mb-QTL) may be important to understanding the relationship between variant carrier status and heterogeneity in susceptibility to IBD [4].”
Regulation of Host Immunity by the Gut Microbiota
Partney, H., & Yissachar, N. (2022) · Progress in inflammation research · doi:10.1007/978-3-030-91051-8_4 · Cited by 7
Evolutionary Insights Into Microbiota Transplantation in Inflammatory Bowel Disease
Wang, X., Zhao, J., Feng, Y., Feng, Z., Ye, Y., Liu, L., Kang, G., & Cao, X. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.916543 · Cited by 8
“, 2013), gastrointestinal diseases [irritable bowel syndrome (IBS) (Pimentel and Lembo, 2020) and IBD (Chu et al., 2016)].”
BackgroundCui, X., Chen, F., Zhao, J., Li, D., Hu, M., Chen, X., Zhang, Y., & Han, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-28567-3 · Cited by 7
Re-purposing is needed for beneficial bugs, not for the drugs
Ram, H. H., & Dastager, S. G. (2018) · International Microbiology · doi:10.1007/s10123-018-00049-x · Cited by 7
Research Tales from the Clardy Laboratory: Function-Driven Natural Product Discovery
Fukuda, T. T. H., Cassilly, C. D., Gerdt, J. P., Henke, M. T., Helfrich, E. J. N., & Mevers, E. E. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b01086 · Cited by 7
Campillo-Gimenez, L., Ríos-Covián, D., Rivera–Nieves, J., Kiyono, H., Chu, H., & Ernst, P. B. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.752304 · Cited by 6
“In contrast to the healthy gut, IgG is the predominant mucosal isotype in gastritis associated with H. pylori¸ celiac disease and IBD (Brandtzaeg et al., 1986).”
BackgroundInfluentialSelf-citationLee, S. H., You, H., Lee, Y., Baik, H., Paik, J. K., Lee, H., Park, S., Shim, J.-J., Lee, J., & Hyun, S. H. (2021) · Microorganisms · doi:10.3390/microorganisms10010088 · Cited by 9
“The development of various metabolic diseases, including diabetes and GI diseases, is common among the elderly [7,8].”
BackgroundJyonouchi, H., & Geng, L. (2022) · Journal of Medical Case Reports · doi:10.1186/s13256-022-03404-9 · Cited by 6
“Risk variants of genes have been implicated in the onset and progression of IBD, in close association to interactions with gut microbiota [13].”
BackgroundGorreja, F. (2019) · NFS Journal · doi:10.1016/j.nfs.2019.02.001 · Cited by 6
Pathogenic Bacteroides fragilis strains can emerge from gut-resident commensalsPreprint
Oles, R. E., Terrazas, M. C., Loomis, L. R., Neal, M. J., Paulchakrabarti, M., Zuffa, S., Hsu, C.-Y., Ayala, A. V., Lee, M. H., Tribelhorn, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.19.599758 · Cited by 10
“B . fragilis capsular polysaccharides, particularly polysaccharide A (PSA), play a pivotal role in immune tolerance within the gut 18,34,35 , yet it also acts as a virulence factor involved in abscess formation outside the gut 9,17,36 .”
Self-citationArnold, P., Boros, F. A., Mattner, J., Seidel, G., Liu, C., Hensel, I. V., Deun, J. V., Schwendner, R., Müller‐Deile, J., Sopel, N., et al. (2025) · Journal of Extracellular Biology · doi:10.1002/jex2.70093 · Cited by 8
Dou, L., Guo, T., Jin, W., Wang, Y., Huang, J., Chen, C., Liu, X., Wang, C., Zheng, Y., Liu, H., et al. (2026) · ACS Nano · doi:10.1021/acsnano.6c02436 · Cited by 6
Function of autophagy genes in innate immune defense against mucosal pathogens
Cui, X., & Wang, Y. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102456 · Cited by 6
Evidence on the importance of gut microbiota for the immune system
Surapsari, J., Oktarina, M. D., Sundjaya, T., & Wasito, E. (2023) · World Nutrition Journal · doi:10.25220/wnj.v06.s2.0002 · Cited by 5
Zhao, Y., Xiang, Z., Pan, H., Huang, X., Chen, W., & Huang, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34349 · Cited by 7
Yang, Q., Yang, L., Qu, X., & Xiao, D. (2024) · Poultry Science · doi:10.1016/j.psj.2024.104379 · Cited by 5
Involvement of eIF2α in halofuginone-driven inhibition of TGF-β1-induced EMT
Duan, M., Wei, X., Cheng, Z., Liu, D., Fotina, H., Xia, X., & Hu, J. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00042-5 · Cited by 5
“Inflammatory bowel disease (IBD) is a chronic, nonspecific inflammatory disease that causes excessive proliferation of intestinal mesenchymal cells, deposition of extracellular matrix (ECM) in the intestinal wall, and excessive growth of the intestinal myometrium (Chu et al. 2016; Ge et al. 2019).”
BackgroundKumari, M., & Kokkiligadda, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822909-5.00004-6 · Cited by 6
Cao, J., Zhao, Q., Jia, Q., & Li, Y. (2023) · Cellular and Molecular Biology · doi:10.14715/cmb/2023.69.7.29 · Cited by 5
“Despite efforts to address it, it is still unknown how UC develops (2,3).”
BackgroundComposition of the bacterial community in the gastrointestinal tract of Kunming mice
Han, X., Shao, H., Wang, Y., Hu, A., Chen, R., & Chen, Q. (2019) · Electronic Journal of Biotechnology · doi:10.1016/j.ejbt.2019.11.003 · Cited by 6
Commensal bacteria promote type I interferon signaling to maintain immune tolerancePreprint
Ayala, A. V., Hsu, C.-Y., Matsuo, K., Buzun, E., Terrazas, M. C., Loomis, L. R., Lu, H.-H., Park, J. H., Rivaud, P., Thomson, M. W., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.21.464743 · Cited by 5
Self-citationVers une nouvelle problématique du savoir sur le développement
Hammouda, H. B. (1997) · Alternatives sud · Cited by 5
TSP50 deficiency in neural stem cells aggravates colitis in mice by altering intestinal microbiome
Li, X., Jin, R., Wang, Z., Niu, C., Song, Z., Liu, X., Huang, J., Zhang, H., Qian, X., Gao, F., et al. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00737-3 · Cited by 6
An Inflammatory Bowel Diseases Integrated Resources Portal (IBDIRP)
Nie, K., Qingsong, C., Ma, K., Weiwei, L., Xing, W., Chen, X., Cai, L., Deng, M., Yuanyuan, Y., & Xiaoyan, W. (2024) · Database · doi:10.1093/database/baad097 · Cited by 5
“However, most genetic variants have a relatively minor effect on disease risk (11), and up to 80–90% of GWAS-identified loci are restricted to noncoding variations that exert their pathogenic effects via gene expression modulation (40).”
BackgroundKaga, C., Nagino, T., Atsushi, G. O. M. I., Takagi, A., Miyazaki, K., Yoshida, Y., & Shida, K. (2024) · Beneficial Microbes · doi:10.1163/18762891-bja00003 · Cited by 6
Fuentes, J. J., Singh, S., Pudlo, N. A., Heaver, S. L., Ley, R. E., & Martens, E. C. (2025) · Journal of Bacteriology · doi:10.1128/jb.00178-25 · Cited by 4
“Cell surface features like CPS and S-layers have other interactions with environmental features like the host immune system and fiber polysaccharides (36, 63, 66–68) and, as shown here, are further influenced by the carbohydrates B. thetaiotaomicron utilizes.”
Su, T., Liu, R., Long, Y., Quan, S., Lai, S., Wang, L., Si, J., & Chen, S. (2018) · Current Microbiology · doi:10.1007/s00284-017-1378-8 · Cited by 4
Exploiting the gut microbiota’s fermentation capabilities towards disease prevention
Gurry, T., & Scapozza, L. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113469 · Cited by 4
Liu, T., Xu, P., Du, Y., Lu, H. J., Zhao, H., & Wang, T. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab443 · Cited by 5
Zhao, Z., Wu, Z., Wang, C., Cheng, H., Yi, S., Li, K., Li, Z., & Wang, Y. (2018) · Journal of Food Safety · doi:10.1111/jfs.12574 · Cited by 5
Zhang, Y., Fang, Y., Chen, Y., Chen, Q., Liu, W.-W., Xu, M., Xing, L., Wang, R., Wang, L., Yu, N., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148476 · Cited by 3
Metadata
- Authors
- Chu, H., Khosravi, A., Kusumawardhani, I. P., Kwon, A. H. K., Vasconcelos, A. C., Cunha, L. D., Mayer, A. E., Shen, Y., Wu, W.-L., Kambal, A., Targan, S. R., Xavier, R. J., Ernst, P. B., Green, D. R., McGovern, D. P. B., Virgin, H. W., & Mazmanian, S. K.
- Affiliations
- California Institute of Technology (US)
- University of California San Diego (US)
- St. Jude Children's Research Hospital (US)
- Washington University in St. Louis (US)
- Cedars-Sinai Medical Center (US)
- Harvard University (US)
- Corresponding author
- Chu, Hiutung
- Mazmanian, Sarkis K.
- ORCID
- Venue
- Science
- Published
- 2016-05-27
- Volume
- 352
- Issue
- 6289
- Pages
- 1116-1120
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4996125
- OpenAlex
- W2346233234
- Cited by
- 647
- References
- 48
- Citations by year
- 2026: 50 · 2025: 55 · 2024: 60 · 2023: 64 · 2022: 57 · 2021: 69 · 2020: 68 · 2019: 77 · 2018: 56 · 2017: 65 · 2016: 24
- FWCI
- 59.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Institutes of Health (NIH)
- Ruth L. Kirschtein National Research Service Award (DK100109)
- Cedars-Sinai F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute Research Funds
- Feintech Family Chair
- Wayne and Gladys Valley Foundation
- Lupus Research Institute
- Lisa Z. Greer Endowed Chair
- European Union (305479)
- Leona M. and Harry B. Helmsley Charitable Trust
- NIH (DK097485, PO1DK046763, AI079145, AI40646, U19 AI109725, DK062413, DE023789-01, AI109725, DK078938, GM099535)
- Crohn's and Colitis Foundation of America
- Heritage Medical Research Institute
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- inflammatory bowel disease, Bacteroides fragilis, outer membrane vesicles, ATG16L1, NOD2, non-canonical autophagy, dendritic cells, regulatory T cells, colitis, gut dysbiosis, susceptibility genes, mucosal inflammation
- MeSH terms
- Extracellular Vesicles, Gastrointestinal Microbiome, Autophagy-Related Proteins, Adult, Aged, Animals, Autophagy, Bacteroides fragilis, Carrier Proteins, Dendritic Cells, Female, Humans, Intestinal Mucosa, Male, Mice, Inbred C57BL, Middle Aged, Polymorphism, Genetic, Inflammatory Bowel Diseases, Genome, Human, Genetic Predisposition to Disease, T-Lymphocytes, Regulatory, Mice, Nod2 Signaling Adaptor Protein, Gene-Environment Interaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.